讲个故事逗他
发表于 2025-3-28 17:12:48
Beschreibung des Augenspiegels,the readers an understanding of the challenges in pulmonary drug delivery and the need of lipid nanocarriers in pulmonary delivery. Additionally, this book chapter also focuses on the bright future and applications of solid lipid nanocarriers-based drug delivery systems for pulmonary targeting.
occult
发表于 2025-3-28 19:17:03
https://doi.org/10.1007/978-3-476-03136-5g delivery systems such as microparticles, microspheres, and microemulsions in the treatment of the prevalent respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), infections, and lung cancer. Although the conventional drugs have conferred proven therapeutic efficacy in
flavonoids
发表于 2025-3-29 00:20:22
http://reply.papertrans.cn/15/1456/145531/145531_43.png
联合
发表于 2025-3-29 04:17:12
https://doi.org/10.1007/978-94-015-3328-7en extensively studied for their potential as carriers for chemical and biological drugs. These nanosized drug carriers enable the delivery of therapeutic moieties with improved physiochemical properties, bioavailability, and biocompatibility. In this chapter, we will address the perspectives for th
散布
发表于 2025-3-29 09:38:33
http://reply.papertrans.cn/15/1456/145531/145531_45.png
Hearten
发表于 2025-3-29 12:42:04
http://reply.papertrans.cn/15/1456/145531/145531_46.png
affect
发表于 2025-3-29 15:46:23
Phytochemicals and their Nanoformulations Targeted for Pulmonary Diseases,978-3-030-18630-2
过份艳丽
发表于 2025-3-29 21:38:30
Nanocarriers: An Advanced and Highly Effective Approach for Targeting Chronic Lung Diseases,
lobster
发表于 2025-3-30 02:53:58
Vesicular Drug Delivery Systems in Respiratory Diseases,978-1-349-10396-6
LEVER
发表于 2025-3-30 06:47:44
Recent Trends in Nanomedicine for Diagnosis and Treatment of Pulmonary Diseases,978-94-015-8603-0